Review
Open access
Aug 2026
IL-17 ligand-targeting inhibitors in psoriatic arthritis: a focused systematic review and network meta-analysis of efficacy, safety, and certainty of evidence
Background IL-17 pathway inhibitors are established treatments for active psoriatic arthritis (PsA), but comparative evidence within this therapeutic class remains limited. We compared the efficacy, safety, treatment rankings, and certainty of evidence for established and emerging IL-17 pathway inhibitors in adults wit...
Yahya Kayed AbuJwaid, A. K. Assi, A. Amro et al.
· Frontiers in Immunology · 0 citations